Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
被引量:4
Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
摘要
AIMTo compare the efficacy of ranibizumab and bevacizumab for macular edema due to retinal vein occlusion (RVO).
AIMTo compare the efficacy of ranibizumab and bevacizumab for macular edema due to retinal vein occlusion (RVO).
参考文献13
-
1Daniel F. Martin,Maureen G. Maguire,Stuart L. Fine,Gui-shuang Ying,Glenn J. Jaffe,Juan E. Grunwald,Cynthia Toth,Maryann Redford,Frederick L. Ferris.Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration[J]. Ophthalmology . 2012 (7)
-
2David Boyer,Jeffrey Heier,David M. Brown,W. Lloyd Clark,Robert Vitti,Alyson J. Berliner,Georg Groetzbach,Oliver Zeitz,Rupert Sandbrink,Xiaoping Zhu,Karola Beckmann,Julia A. Haller.Vascular Endothelial Growth Factor Trap-Eye for Macular Edema Secondary to Central Retinal Vein Occlusion[J]. Ophthalmology . 2012 (5)
-
3Peter A. Campochiaro,David M. Brown,Carl C. Awh,S. Young Lee,Sarah Gray,Namrata Saroj,Wendy Yee Murahashi,Roman G. Rubio.Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study[J]. Ophthalmology . 2011 (10)
-
4David M. Brown,Peter A. Campochiaro,Robert B. Bhisitkul,Allen C. Ho,Sarah Gray,Namrata Saroj,Anthony P. Adamis,Roman G. Rubio,Wendy Yee Murahashi.Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study[J]. Ophthalmology . 2011 (8)
-
5Dimitrios A. Karagiannis,Michael D. Karampelas,Vasileios M. Soumplis,Christos Amariotakis,Ilias Georgalas,Artemios Kandarakis.Recurrence of macular edema in retinal vein occlusions after treatment with intravitreal ranibizumab (Lucentis)[J]. Canadian Journal of Ophthalmology/Journal canadien d’ophtalmologie . 2011 (6)
-
6Julia A. Haller,Francesco Bandello,Rubens Belfort,Mark S. Blumenkranz,Mark Gillies,Jeffrey Heier,Anat Loewenstein,Young-Hee Yoon,Marie-Louise Jacques,Jenny Jiao,Xiao-Yan Li,Scott M. Whitcup.Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion[J]. Ophthalmology . 2010 (6)
-
7Richard F. Spaide,Louis K. Chang,James M. Klancnik,Lawrence A. Yannuzzi,John Sorenson,Jason S. Slakter,K. Bailey Freund,Robert Klein.Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion[J]. American Journal of Ophthalmology . 2009 (2)
-
8Gesine B. Jaissle,Martin Leitritz,Faik Gelisken,Focke Ziemssen,Karl Ulrich Bartz-Schmidt,Peter Szurman.One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion[J]. Graefe’s Archive for Clinical and Experimental Ophthalmology . 2009 (1)
-
9Qi Zhu,Focke Ziemssen,Sigrid Henke-Fahle,Olcay Tatar,Peter Szurman,Sabine Aisenbrey,Nicole Schneiderhan-Marra,Xun Xu,Salvatore Grisanti.Vitreous Levels of Bevacizumab and Vascular Endothelial Growth Factor-A in Patients with Choroidal Neovascularization[J]. Ophthalmology . 2008 (10)
-
10Dante J. Pieramici,Melvin Rabena,Alessandro A. Castellarin,Ma’an Nasir,Robert See,Tamara Norton,Andres Sanchez,Sarah Risard,Robert L. Avery.Ranibizumab for the Treatment of Macular Edema Associated with Perfused Central Retinal Vein Occlusions[J]. Ophthalmology . 2008 (10)
共引文献4
-
1Ahmadreza Moradi,Yasir Jamal Sepah,Mohammad Ali Sadiq,Humzah Nasir,Salima Kherani,Raafay Sophie,Diana V Do,Quan Dong Nguyen.Vascular endothelial growth factor trap-eye(Aflibercept) for the management of diabetic macular edema[J].World Journal of Diabetes,2013,4(6):303-309. 被引量:8
-
2Claudia Krispel,Murilo Rodrigues,Xiaoban Xin,Akrit Sodhi.Ranibizumab in diabetic macular edema[J].World Journal of Diabetes,2013,4(6):310-318. 被引量:3
-
3Xiao-Ling Zhang,Jian Chen,Ri-Jia Zhang,Wen-Jie Wang,Qing Zhou,Xiao-Yan Qin.Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema:a meta-analysis[J].International Journal of Ophthalmology(English edition),2013,6(4):546-552. 被引量:5
-
4Haiyan Wang,Giulio Barteselli,William R.Freeman,Su Na Lee,Jay Chhablani,Sharif El-Emam,Lingyun Cheng.Temporal pattern of resolution/recurrence of choroidal neovascularization during bevacizumab therapy for wet age-related macular degeneration[J].International Journal of Ophthalmology(English edition),2013,6(5):600-605. 被引量:5
同被引文献21
-
1Wei Chen,Ying Wu,Mi Zheng,Qing Gu,Zhi Zheng,Xin Xia.Establishing an experimental rat model of photo-dynamically-induced retinal vein occlusion using erythrosin B[J].International Journal of Ophthalmology(English edition),2014,7(2):232-238. 被引量:7
-
2Kenan Sonmez,Faruk Ozturk.Complications of intravitreal triamcinolone acetonide for macular edema and predictive factors for intraocular pressure elevation[J].International Journal of Ophthalmology(English edition),2012,5(6):719-725. 被引量:10
-
3杨文芝,吴强.视网膜静脉阻塞治疗新进展[J].眼科新进展,2010,30(7):694-697. 被引量:11
-
4秦常军,吴怡,于桂梅.和血明目片治疗视网膜静脉阻塞所致眼底出血的疗效观察[J].国际眼科杂志,2010,10(12):2391-2392. 被引量:6
-
5喻青,李志敏,王鲜,冯秉民.和血明目片联合氪激光治疗视网膜静脉阻塞的临床疗效[J].国际眼科杂志,2011,11(1):138-139. 被引量:4
-
6廖良,韦企平.和血明目片参与治疗眼底出血性疾病的系统评价[J].湖南中医药大学学报,2010,30(12):65-67. 被引量:8
-
7苏钰,陈长征,李璐,郁想想,郑红梅,李菲.玻璃体腔注射Bevacizumab与曲氨奈德治疗视网膜静脉阻塞继发黄斑水肿比较研究[J].武汉大学学报(医学版),2011,32(3):338-342. 被引量:8
-
8孟丽红,王丽娟,武宏理.复方血栓通胶囊治疗视网膜静脉阻塞的效果观察[J].国际眼科杂志,2012,12(3):552-553. 被引量:28
-
9罗旭昇,吴宁玲,郝进.黄斑水肿证治思考[J].中国中医眼科杂志,2013,23(1):49-51. 被引量:11
-
10姚静虹,罗莎莎,袁志兰,王道德.小鼠慢性高眼压模型下视网膜神经节细胞的损伤[J].现代生物医学进展,2013,13(16):3010-3013. 被引量:1
引证文献4
-
1陈泽华,付彩云,刘俊,黎其友,阴正勤.视网膜静脉阻塞与颈动脉狭窄的相关性研究[J].现代生物医学进展,2014,14(33):6467-6469. 被引量:5
-
2高颖,周剑,韦企平.益气活血中药与玻璃体腔注射曲安奈德治疗黄斑水肿疗效比较[J].中国中医眼科杂志,2015,25(5):327-330. 被引量:9
-
3龙盘,吴一冰,赵健,张作明,安晶.视网膜静脉阻塞药物治疗方法和进展[J].国际眼科杂志,2017,17(11):2055-2059. 被引量:10
-
4郎需强,王康,李爽,杨杨,郭祈涵.脉络膜血管指数在视网膜中央静脉阻塞治疗预后评估中价值初步分析[J].临床眼科杂志,2019,27(4):298-303. 被引量:3
二级引证文献27
-
1段小莉.庆阳市居民视网膜静脉阻塞发病情况及危险因素调查[J].中国公共卫生管理,2017,33(1):84-85. 被引量:2
-
2陈梦平.黄斑消肿汤联合激光治疗视网膜静脉阻塞伴黄斑水肿临床研究[J].亚太传统医药,2017,13(15):129-130. 被引量:6
-
3庞凤,刘国军.益气活血利湿汤联合雷珠单抗玻璃体腔注射对糖尿病性黄斑水肿的疗效观察[J].中国中医眼科杂志,2017,27(4):246-249. 被引量:8
-
4冯宝平,杨建玲,申亚贤.益气活血中药联合曲安奈德及532激光治疗视网膜分支静脉阻塞继发黄斑水肿疗效观察[J].现代中西医结合杂志,2018,27(21):2296-2298. 被引量:7
-
5陈伽俐,窦晓燕,杨浩江,李炜,熊华花.视网膜静脉阻塞与颈动脉血液流变学的相关性[J].中华眼外伤职业眼病杂志,2018,40(8):634-637. 被引量:2
-
6龙盘,严伟明,陈涛,王建丛,李曼红,薛军辉,安晶,张作明.光化学法建立视网膜分支静脉阻塞大鼠模型及相关研究[J].国际眼科杂志,2018,18(5):801-806. 被引量:3
-
7纪敏,杨曙涛.康柏西普联合激光治疗视网膜静脉血管阻塞并发黄斑囊样水肿疗效观察[J].中国药业,2019,28(3):68-70. 被引量:11
-
8韩嵩.复方血栓通软胶囊联合眼底激光治疗视网膜静脉阻塞的临床效果[J].中国民康医学,2019,31(6):104-105. 被引量:5
-
9周宇,陈俞兵,胡佳雯.益气活血利湿汤对糖尿病视网膜病变模型大鼠炎症因子及视神经保护作用[J].浙江中西医结合杂志,2019,29(8):627-631. 被引量:12
-
10杨红伟,杨倩倩,刘德成,郭春峰.后部眼球筋膜下注射曲安奈德联合光凝治疗黄斑水肿[J].中华眼外伤职业眼病杂志,2019,41(8):607-611. 被引量:1
-
1方丽华,郎林福,方臻,王德法.视网膜电图检测对视网膜静脉阻塞视功能的评价[J].临床眼科杂志,2000,8(1):13-14.
-
2姚曼,郑燕林,高明敏,彭晓丽,赵辰.玻璃体腔注射曲安奈德术后角膜内皮细胞变化的初步观察[J].中医眼耳鼻喉杂志,2013,3(2):83-85.
-
3高海英,杨连静.视网膜静脉阻塞的临床分析[J].山西医药杂志,2005,34(10):851-852.
-
4Hai-Yan Wang,Xiao Li,Yus-Sheng Wang,Zi-Feng Zhang,Man-Hong Li,Xiao-Na Su,and Jin-Ting Zhu.Intravitreal injection of bevacizumab alone or with triamcinolone acetonide for treatment of macular edema caused by central retinal vein occlusion[J].International Journal of Ophthalmology(English edition),2011,4(1):89-94. 被引量:8
-
5张思远,吕红彬.黄斑水肿治疗进展[J].泸州医学院学报,2016,39(3):218-222. 被引量:10
-
6张怡,高素珍,李华.氩激光光凝治疗视网膜静脉阻塞的临床观察[J].临床眼科杂志,2000,8(5):376-377. 被引量:6
-
7滕克禹,戴军,赵军.视网膜分枝静脉阻塞的视网膜电图和图形视诱发电位的观察[J].眼科,2000,9(1):25-27. 被引量:3
-
8Mustafa Alpaslan Anayol,Yasin Toklu,Elif Asik Kamberoglu,Sabri Raza,Hasan Basri Arifoglu,Huseyin Simavli,Ayse Gul Kocak Altintas,Saban Simsek.Short-term effects of intravitreal triamcinolone acetonide injection on ocular blood flow evaluated with color Doppler ultrasonography[J].International Journal of Ophthalmology(English edition),2014,7(5):811-815. 被引量:4
-
9李鹏,王莉,高丹宇.曲安奈德玻璃体腔注射治疗黄斑水肿的临床观察[J].国际眼科杂志,2007,7(6):1720-1721. 被引量:15
-
10刘银萍,梅立新.视网膜激光光凝联合通塞脉片治疗视网膜静脉阻塞疗效观察[J].临床眼科杂志,2016,24(2):146-148. 被引量:6